Insights into the Cholecystokinin 2 Receptor Binding Site and Processes of Activation

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular Pharmacology

• Publication date

  2006-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/mol.106.029967PMID 16998007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mechanism of 7TM receptor activation--a global toggle switch model.

  2006cited by this paper
• Cholecystokinin receptors

  2005cited by this paper
• Computational modeling approaches to structure-function analysis of G protein-coupled receptors.

  2005cited by this paper
• The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice.

  2004cited by this paper
• Gastrins, cholecystokinins and gastrointestinal cancer.

  2004cited by this paper
• An Antiapoptotic Role for Gastrin and the Gastrin/CCK-2 Receptor in Barrett’s Esophagus

  2004cited by this paper
• Constitutively Active G Protein-Coupled Receptor Mutants: Implications on Receptor Function and Drug Action

  2003cited by this paper
• High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor

  2003cited by this paper
• Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.

  2003cited by this paper
• Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity

  2003cited by this paper
• Lessons from constitutively active mutants of G protein-coupled receptors.

  2002cited by this paper
• The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop.

  2002cited by this paper
• A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron.

  2002cited by this paper
• Gastrin, CCK, signaling, and cancer.

  2001cited by this paper
• Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6*

  2001cited by this paper
• Mutation of Asn-391 within the Conserved NPXXY Motif of the Cholecystokinin B Receptor Abolishes Gq Protein Activation without Affecting Its Association with the Receptor*

  2000cited by this paper
• The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.

  2000cited by this paper
• Movement of retinal along the visual transduction path.

  2000cited by this paper
• The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.

  2000cited by this paper
• The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor.

  2000cited by this paper
• Therapeutic and chemical developments of cholecystokinin receptor ligands

  2000cited by this paper
• Human Colorectal Cancers Express a Constitutively Active Cholecystokinin-B/Gastrin Receptor That Stimulates Cell Growth*

  2000cited by this paper
• Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.

  2000cited by this paper
• Evidence for a Direct Interaction between the Penultimate Aspartic Acid of Cholecystokinin and Histidine 207, Located in the Second Extracellular Loop of the Cholecystokinin B Receptor*

  1999influential reference
• Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6.

  1999cited by this paper
• pi-Stacking interactions. Alive and well in proteins.

  1998influential reference
• Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.

  1998cited by this paper
• Role of the extracellular domains of the cholecystokinin receptor in agonist binding.

  1998cited by this paper
• Minor Modifications of a Cholecystokinin-B/Gastrin Receptor Non-peptide Antagonist Confer a Broad Spectrum of Functional Properties*

  1998influential reference
• Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.

  1997cited by this paper
• The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate.

  1997cited by this paper
• A Segment of Five Amino Acids in the Second Extracellular Loop of the Cholecystokinin-B Receptor Is Essential for Selectivity of the Peptide Agonist Gastrin*

  1996cited by this paper
• [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors

  1995cited by this paper
• Cholecystokinin receptors.

  1995cited by this paper
• A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin.

  1994cited by this paper
• Constitutive activation of opsin: influence of charge at position 134 and size at position 296.

  1993cited by this paper
• Role of the intradiscal domain in rhodopsin assembly and function.

  1990cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Annual Review of Pharmacology

  1975cited by this paper

• Rational Design of Drug Formulations using Computational Approaches

  2013cites this paper
• Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling.

  2013cites this paper
• Update 1 of: computational modeling approaches to structure-function analysis of G protein-coupled receptors.

  2011cites this paper
• Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation.

  2010cites this paper
• Ciblage peptidique en oncologie nucléaire : intérêt de la modélisation moléculaire

  2010cites this paper
• Structural basis of cholecystokinin receptor binding and regulation.

  2008cites this paper
• Molecular Basis for Agonist Selectivity and Activation of the Orphan Bombesin Receptor Subtype 3 Receptor

  2008influential citation
• Predicting the Solubility of the Anti-Cancer Agent Docetaxel in Small Molecule Excipients using Computational Methods

  2007influential citation